Crossmark

Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease

Crossref DOI link: https://doi.org/10.1007/s40620-022-01508-5

Published Online: 2022-11-24

Published Print: 2023-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Mengyue

Wang, Jingjing

Le, Weibo

Xu, Feng

Jin, Ying

Jiao, Chenfeng

Zhang, Haitao
Funding

Funding for this research was provided by:

National Key Research and Development Project of China (2021YFC2501302)

National Key Research and Development Project of China (2021YFC2501302)
License Information

Version of Record valid from 2022-11-24

Text and Data Mining valid from 2022-11-24

Version of Record valid from 2022-11-24
More Information

Article History

Received: 17 July 2022

Accepted: 19 October 2022

First Online: 24 November 2022

Declarations

:

: All the authors declare no competing interests.

: This study was approved by the ethics committee of Jinling Hospital (2022DZKY-033-01), and was carried out following the principles of the Helsinki Declaration.